NCT07000864招募中不适用
Predicting Response to Therapy From Analysis of Live Tumor Fragments of Surgical Resections
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- Mayo Clinic
- 入组人数
- 250
- 试验地点
- 2
- 主要终点
- Tissue response to treatment
研究概览
简要总结
The purpose of this study is to obtain unused resected tumor tissue sample and associated clinical data from patients enrolled in this study to research ex vivo treatment response and integrity of tumor microenvironment using omics analysis and imaging while maintaining cell stability in a live environment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Ability to understand and sign informed consent
- •Planning to undergo a surgical procedure to remove cancer
排除标准
- •Does not meet Inclusion criteria
- •No tissue for research available at time of surgery
结局指标
主要结局
Tissue response to treatment
时间窗: Up to 72 hours
Tumor sample fragments will be treated with various combination of chemotherapy and immunotherapy drugs that are commonly used to treat patients clinically (panel of drugs will be selected based on cancer type). response to the treatment will be assessed at multiple timepoints during a 72-hour period.
次要结局
未报告次要终点
研究者
Debabrata Mukhopadhyay, PhD
Principal Investigator
Mayo Clinic
研究点 (2)
Loading locations...
相似试验
招募中
不适用
A Multicenter Cancer Biospecimen Collection StudyCancer of Head and NeckLung Cancer, Nonsmall CellSmall-cell Lung CancerUrothelial CarcinomaGastroesophageal Junction AdenocarcinomaEsophageal Squamous Cell CarcinomaTriple Negative Breast CancerColorectal CancerHepatocellular CarcinomaCervical CancerRenal Cell CarcinomaNCT04510129Cofactor Genomics, Inc.1,650
已完成
2 期
Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)MelanomaBladder CancerNCT02553642Memorial Sloan Kettering Cancer Center81
已完成
不适用
Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy.Breast NeoplasmNCT03273426Seoul National University Hospital40
已完成
不适用
Monitoring Plasma Tumor DNA in Early-Stage Breast CancerBreast CancerNCT02743910Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins228
已完成
不适用
Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic CancerPancreatic CancerNCT00897832Vanderbilt-Ingram Cancer Center50